Hopes for a separate board responsible for certifying cardiologists were dashed Friday when leaders laying the groundwork for ...

Clinicians having unconscious pro-white bias led to low-value PAD care and greater risks for amputation in Black patients.

For all news and slides from the THT 2025 meeting, check out our conference page and or tune in to the Heart Sounds podcast ...

Guidance around complete revascularization and intracoronary imaging is strengthened, and Impella gets a recommendation.

The polygenic risk score appears to identify patients who may benefit most from LDL-lowering therapy, say researchers.

The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.

A study comparing GLP-1 users to others on antidiabetic drugs showed no added risk once confounders were accounted for.

There’s no scientific evidence to support anecdotal claims—on social media or elsewhere—of a bump, Jonathan Drezner says.

This month: smelling skills predict stroke risk, insights from LGBTQ+ clinicians, BP screening in public spaces, and more.

A patient who, despite risk factors or comorbidities, can get on a treadmill faces low mortality risk. But the reverse is ...

The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.

The polygenic risk score appears to identify patients who may benefit most from LDL-lowering therapy, say researchers.